Genmab (GMAB) Event July 19, 2022, 12:14 UTC (99% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K) Full text
Register to leave comments News bot Oct. 18, 2025, 5:59 p.m. 🌍 Genmab (GMAB) - Form 6-K Filing Filing Date: 2022-07-19 Accepted: 2022-07-19 08:14:04 Event Type: Clinical Trial Update Event Details: Net trade sales were USD 1,021 million in the U. and USD 965 million in the rest of the world. About Genmab Genmab is an international biotechnology company with a core purpose to improve the lives of people with cancer. 💼 Business Developments: ✅ Partnership/Collaboration❌ Acquisition Activity: Not reported❌ Licensing Agreement: Not reported❌ Regulatory Milestone: Not reported❌ Leadership Updates: Not reported 📞 Contact Information: Email: mmp@genmab.com
🌍 Genmab (GMAB) - Form 6-K Filing
Filing Date: 2022-07-19
Accepted: 2022-07-19 08:14:04
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
📞 Contact Information: